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Received 23 June 2011; accepted 25 June 2011Diagnosing and treating acromegaly are difficult when
imaging of the pituitary gland fails to show an adenoma.
Inferior petrosal sinus sampling (IPSS) is a useful diagnostic
technique that can aid in both the localization of tumors
and lateralization within the pituitary gland. However,
some severe neurological complications have been repor-
ted in the literature, including brain stem injuries,1
thromboembolism,2,3 isolated sixth nerve palsy,4 and
venous subarachnoid hemorrhage.5 Here, we report a rare
complication of left homonymous upper quadrantanopia
after inferior petrosal sinus sampling.
A 58-year-old woman with a 10-year history of hyper-
tension was referred to our endocrine clinic for evaluation
of acromegaly. She presented with macroglossia, progna-
thism, and acral enlargement of both hands. Her visual field
test was normal. An elevated insulin-like growth factor-1
(IGF-1) level of 902 ng/mL and a nadir growth hormone (GH)
level of 8.7 ng/mL on the oral glucose tolerance test
confirmed the diagnosis of acromegaly. Magnetic resonance
imaging (MRI) revealed an empty sella but no evidence of
a pituitary adenoma (Fig. 1A). An 111In-octreotide scan did
not show evidence of ectopic or GH-secreting tumor, so we
decided to use IPSS to determine the source of pituitary GH* Corresponding author. Division of Endocrinology and Metabo-
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between 139/87e166/106 mmHg. The procedure pro-
ceeded without incident until some minutes later, when the
patient complained of a mild headache. Venous sampling
was simultaneously performed from the bilateral inferior
petrosal sinus and the right femoral sheath at 0, 2, 5, and
10 minutes into the procedure.
Approximately 3 hours after the procedure, the patient
complained of a worsening headache and blurred vision. MRI
demonstrated an acute infarction near the right posterior
cerebral artery (Fig. 1B). Magnetic resonance angiography
showed no abnormalities of cervicocranial vessels. Repeated
visual field tests indicated left homonymous superior quad-
rantanopia (Fig. 1C). The patient was treated with hydration
and aspirin, then discharged 6 days after the procedure. The
results of IPSS did not show a significant central-to-peripheral
gradient. In view of the equivocal results of the IPSS and
imaging studies to localize the source of the GH secretion,
the patient refused pituitary exploration. She was treated
with cabergoline and lanreotide. At a follow-up examination
1 year after IPSS, the patient still had persistent visual field
deficits. Her fasting GH level was 6.15 ng/mL, and her IGF-1
level had decreased to 585 ng/mL.
There are no guidelines for the treatment of patients
with acromegaly, negative findings on pituitary imaging,
and no evidence of ectopic GH production. Medical therapy
or transsphenoidal pituitary exploration are the reasonable
treatment options for these cases. In this case, the region& Formosan Medical Association. All rights reserved.
Figure 1 (A) Pituitary MRI showing an empty sella with a thin layer of soft tissues over the fossa. (B) Brain MRI showing a diffuse
hyperintensity from the right temporal lobe to the occipital lobe on T2-weighted imaging. (C) Visual field test demonstrating left
homonymous superior quadrantanopia.
296 T.-Y. Yu et al.of injury on MRI was consistent with the patient’s neuro-
logic examination and presence of upper-right optic radia-
tion from the lateral geniculate body. The complications
associated with IPSS are rare but have fueled the contro-
versy surrounding the exact role of IPSS in the evaluation of
pituitary diseases. Physicians should formulate treatment
decisions based on accurate risk-benefit analyses. With
strict adherence to these indications, we believe that IPSS
remains as a safe and useful tool in the hands of an expe-
rienced radiologist.
References
1. Sturrock N, Jeffcoate WJ. A neurological complication of infe-
rior petrosal sinus sampling during investigation for Cushing’sdisease: a case report. J Neurol Neurosurg Psychiatr 1997;62:
527e8.
2. Blevins Jr LS, Clark RV, Owens DS. Thromboembolic complica-
tions after inferior petrosal sinus sampling in patients with
Cushing’s syndrome. Endocr Pract 1998;4:365e7.
3. Obuobie K, Davies J, Ogunko A, Scanlon MF. Venous thrombo-
embolism following inferior petrosal sinus sampling in Cush-
ing’s disease. J Endocrinol Invest 2000;23:542e4.
4. Lefournier V, Gatta B, Martinie M, Vasder A, Tabarin A,
Bessou P, et al. One transient neurological complication (sixth
nerve palsy) in 166 consecutive inferior petrosal sinus
samplings for the etiological diagnosis of Cushing’s syndrome. J
Clin Endocrinol Metab 1999;84:3401e2.
5. Bonelli FS, Huston 3rd J, Meyer FB, Carpenter PC. Venous
subarachnoid hemorrhage after inferior petrosal sinus sampling
for adrenocorticotropic hormone. AJNR Am J Neuroradiol
1999;20:306e7.
